Our Summary

The study investigated the occurrence of new uterine adhesions (scar-like tissues that can form inside the uterus) following a specific treatment for uterine fibroids called transcervical fibroid ablation (TFA) using the Sonata system. Uterine fibroids are non-cancerous growths that develop in the uterus. In the study, 37 patients with symptomatic uterine fibroids underwent this treatment and were then checked for new adhesions six weeks later. From the 35 patients who completed the study, no new adhesions were found, suggesting that the risk of developing these adhesions after TFA with the Sonata system might be low. This is significant as adhesions can lead to fertility issues and other complications.

FAQs

  1. What is transcervical fibroid ablation (TFA) using the Sonata system?
  2. What are the risks of developing uterine adhesions after TFA with the Sonata system?
  3. Can uterine adhesions formed after TFA lead to fertility issues?

Doctor’s Tip

A doctor might tell a patient undergoing uterine ablation to follow up with regular check-ups and screenings to monitor for any potential complications, such as the formation of new uterine adhesions. It is also important to report any new or worsening symptoms to your healthcare provider promptly. Additionally, maintaining a healthy lifestyle, including regular exercise and a balanced diet, can help support overall uterine health and recovery after the procedure.

Suitable For

Patients who are typically recommended uterine ablation are those who suffer from heavy menstrual bleeding, painful periods, or other symptoms of uterine fibroids that have not responded to other treatment options. Uterine ablation is often considered for patients who do not wish to have a hysterectomy or who are not candidates for surgery. It is important for patients to discuss their symptoms and treatment options with their healthcare provider to determine if uterine ablation is the right choice for them.

Timeline

  • Before uterine ablation:
  1. Patient experiences symptoms of uterine fibroids such as heavy menstrual bleeding, pelvic pain, and frequent urination.
  2. Patient consults with a healthcare provider who recommends uterine ablation as a treatment option.
  3. Patient undergoes pre-operative evaluations and tests to ensure they are a suitable candidate for the procedure.
  4. Patient schedules the uterine ablation procedure.
  • After uterine ablation:
  1. Patient undergoes the uterine ablation procedure, which involves destroying the lining of the uterus to reduce or stop menstrual bleeding.
  2. Patient may experience mild cramping and spotting in the days following the procedure.
  3. Patient is advised to rest and avoid strenuous activities for a few days.
  4. Patient follows up with their healthcare provider for post-operative care and monitoring.
  5. Patient experiences a reduction in symptoms such as heavy menstrual bleeding and pelvic pain over time.
  6. In the case of the study mentioned, patient is checked for new uterine adhesions six weeks after the procedure, with no new adhesions found in the participants.
  7. Patient may need additional follow-up appointments to monitor their condition and ensure the effectiveness of the uterine ablation procedure.

What to Ask Your Doctor

  1. What is uterine ablation and how does it work?
  2. Am I a good candidate for uterine ablation with the Sonata system?
  3. What are the potential risks and complications associated with uterine ablation?
  4. How effective is uterine ablation in treating my symptoms or condition?
  5. Will uterine ablation affect my fertility or ability to have children in the future?
  6. How long is the recovery period after uterine ablation?
  7. Are there any lifestyle changes or restrictions I need to follow after the procedure?
  8. Will I need any follow-up appointments or monitoring after uterine ablation?
  9. What other treatment options are available for my condition if uterine ablation is not successful?
  10. Can you provide me with more information or resources about uterine ablation with the Sonata system?

Reference

Authors: Bongers M, Quinn SD, Mueller MD, Krämer B, Tuschy B, Sütterlin M, Bassil Lasmar R, Chudnoff S, Thurkow A, De Wilde RL. Journal: Eur J Obstet Gynecol Reprod Biol. 2019 Nov;242:122-125. doi: 10.1016/j.ejogrb.2019.09.013. Epub 2019 Sep 23. PMID: 31580964